Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study

2018-07-30T19:42:49Z (GMT) by Katie Paul-Friedman Russell Thomas
Presentation at RIVM (Netherlands National Institute for Public Health and the Environment) visit to EPA April 2018